Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration

Abstract Introduction Photobiomodulation (PBM) has become a promising approach for slowing the progression of early and intermediate dry age-related macular degeneration (dAMD) to advanced AMD. This technique uses light to penetrate tissues and activate molecules that influence biochemical reactions...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Enrico Borrelli, Giulia Coco, Marco Pellegrini, Marco Mura, Nicolò Ciarmatori, Vincenzo Scorcia, Adriano Carnevali, Andrea Lucisano, Massimiliano Borselli, Costanza Rossi, Michele Reibaldi, Federico Ricardi, Aldo Vagge, Massimo Nicolò, Paolo Forte, Antonio Cartabellotta, Murat Hasanreisoğlu, Cem Kesim, Sibel Demirel, Özge Yanık, Federico Bernabei, Pierre-Raphael Rothschild, Sarah Farrant, Giuseppe Giannaccare
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Adis, Springer Healthcare 2024-09-01
Sarja:	Ophthalmology and Therapy
Aiheet:	Age related macular degeneration Drusen Dry AMD Low-level light therapy Photobiomodulation
Linkit:	https://doi.org/10.1007/s40123-024-01030-w
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!